Cormedix Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cormedix

Access the complete profile.

Cormedix Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	300 Connell Drive Suite 4200 Berkeley Heights, NJ 07922

Cormedix's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cormedix's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Cormedix is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Cormedix is a publicly traded company on ASE using the ticker symbol CRMD. Detailed information on company financials and operating reports can be found here: ASE: CRMD

Cormedix Annual Revenue and Growth Rate

Cormedix	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cormedix's revenues are gauged from an analysis of company filings.

Investor Activity

Cormedix has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 3, 2012	8	28%	$3 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Cormedix is developing and marketing. Cormedix doesn't have any recent trademark applications, indicating Cormedix is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DC DEFENCATH (TAUROLIDINE/HEPARIN) Antimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution	06/10/2021
DEFENCATH (TAUROLIDINE/HEPARIN) Antimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution	06/10/2021
DEFENCATH LIMITED POPULATION antimicrobial solution for use as a catheter lock solution	06/10/2021

See all trademarks and details in the Full Report.

Market Share of Cormedix's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cormedix, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Cormedix. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVARTIS	East Hanover, NJ	100
CELGENE	Summit, NJ	14
ALVOGEN GROUP	Morristown, NJ	13
EXELTIS USA	Florham Park, NJ	2
PHATHOM PHARMACEUTICALS	Florham Park, NJ	1
PHARMAHEALTH LABS	Morristown, NJ	1

Other Companies at 300 Connell Drive, Berkeley Heights NJ

Company	Headquarters	Revenue ($ MM)
CONNELL	Berkeley Heights, NJ	100
AEON GLOBAL HEALTH	Berkeley Heights, NJ	31
CHENOA INFORMATION SERVICES	Berkeley Heights, NJ	15
MARQUIS WHOS WHO	Berkeley Heights, NJ	0

Future Competition: Cormedix's Fastest Growing Competitors

These companies are in the same general field as Cormedix and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)